VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
ChemoMetec A/S vs UnitedHealth Group Incorporated
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
ChemoMetec A/S
CHEMM · Nasdaq Copenhagen A/S
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into ChemoMetec A/S's moat claims, evidence, and risks.
View CHEMM analysisUnitedHealth Group Incorporated
UNH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into UnitedHealth Group Incorporated's moat claims, evidence, and risks.
View UNH analysisComparison highlights
- Moat score gap: ChemoMetec A/S leads (67 / 100 vs 64 / 100 for UnitedHealth Group Incorporated).
- Segment focus: ChemoMetec A/S has 2 segments (94.8% in Life science research, cell and gene therapy, and bioprocessing); UnitedHealth Group Incorporated has 4 segments (74.9% in UnitedHealthcare).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Weak.
- Moat breadth: ChemoMetec A/S has 4 moat types across 2 domains; UnitedHealth Group Incorporated has 5 across 2.
Primary market context
ChemoMetec A/S
Life science research, cell and gene therapy, and bioprocessing
Global cell counting and analysis instruments for LCB workflows
Global, skewed to USA/Canada and Europe
Pharmaceutical, biotech, cell and gene therapy, bioprocessing, and research labs
OEM instrument, consumables, software, and service provider
94.8%
UnitedHealth Group Incorporated
UnitedHealthcare
U.S. health benefits / managed care (commercial, Medicare Advantage, Medicaid managed care)
United States (primarily)
Employers, individuals, and government-sponsored programs
Health insurer / managed care organization
74.9%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
ChemoMetec A/S strengths
UnitedHealth Group Incorporated strengths
Segment mix
ChemoMetec A/S segments
Full profile >Life science research, cell and gene therapy, and bioprocessing
Oligopoly
Production control and quality control of animal semen, beer and milk
Quasi-Monopoly
UnitedHealth Group Incorporated segments
Full profile >UnitedHealthcare
Oligopoly
Optum Health
Competitive
Optum Insight
Competitive
Optum Rx
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.